Steven Lo - Net Worth and Insider Trading
Steven Lo Net Worth
The estimated net worth of Steven Lo is at least $731,982 dollars as of 2024-12-27. Steven Lo is the VP Commercial Operations of Corcept Therapeutics Inc and owns about 12,500 shares of Corcept Therapeutics Inc (CORT) stock worth over $670,375. Steven Lo is the Chief Commercial Officer of Puma Biotechnology Inc and owns about 19,557 shares of Puma Biotechnology Inc (PBYI) stock worth over $61,605. Steven Lo is also the CEO of Zosano Pharma Corp and owns about 13,163 shares of Zosano Pharma Corp (ZSANQ) stock worth over $3. Details can be seen in Steven Lo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven Lo has not made any transactions after 2022-06-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven Lo
Steven Lo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven Lo owns 3 companies in total, including Zosano Pharma Corp (ZSANQ) , Puma Biotechnology Inc (PBYI) , and Corcept Therapeutics Inc (CORT) .
Click here to see the complete history of Steven Lo’s form 4 insider trades.
Insider Ownership Summary of Steven Lo
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ZSANQ | Zosano Pharma Corp | 2022-06-06 | director & Chief Executive Officer |
PBYI | Puma Biotechnology Inc | 2019-07-22 | Chief Commercial Officer |
CORT | Corcept Therapeutics Inc | 2015-11-02 | VP Commercial Operations |
Steven Lo Latest Holdings Summary
Steven Lo currently owns a total of 3 stocks. Among these stocks, Steven Lo owns 12,500 shares of Corcept Therapeutics Inc (CORT) as of November 2, 2015, with a value of $670,375 and a weighting of 91.58%. Steven Lo owns 19,557 shares of Puma Biotechnology Inc (PBYI) as of July 22, 2019, with a value of $61,605 and a weighting of 8.42%. Steven Lo also owns 13,163 shares of Zosano Pharma Corp (ZSANQ) as of June 6, 2022, with a value of $3 and a weighting of 0%.
Latest Holdings of Steven Lo
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CORT | Corcept Therapeutics Inc | 2015-11-02 | 12,500 | 53.63 | 670,375 |
PBYI | Puma Biotechnology Inc | 2019-07-22 | 19,557 | 3.15 | 61,605 |
ZSANQ | Zosano Pharma Corp | 2022-06-06 | 13,163 | 0.00 | 3 |
Holding Weightings of Steven Lo
Steven Lo Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven Lo has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the sale of 12,500 shares on November 2, 2015, which brought Steven Lo around $50,000.
According to the SEC Form 4 filings, Steven Lo has made a total of 0 transactions in Puma Biotechnology Inc (PBYI) over the past 5 years. The most-recent trade in Puma Biotechnology Inc is the sale of 1,852 shares on July 22, 2019, which brought Steven Lo around $18,594.
According to the SEC Form 4 filings, Steven Lo has made a total of 3 transactions in Zosano Pharma Corp (ZSANQ) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Zosano Pharma Corp is the sale of 442 shares on June 6, 2022, which brought Steven Lo around $314.
Insider Trading History of Steven Lo
- 1
Steven Lo Trading Performance
Steven Lo Ownership Network
Steven Lo Owned Company Details
What does Zosano Pharma Corp do?
Who are the key executives at Zosano Pharma Corp?
Steven Lo is the director & Chief Executive Officer of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include Chief Financial Officer Christine Matthews , VP & Clinical Dev & Med Affairs Donald J Kellerman , and See Remarks Hayley Lewis .
Zosano Pharma Corp (ZSANQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zosano Pharma Corp Insider Transactions
Steven Lo Mailing Address
Above is the net worth, insider trading, and ownership report for Steven Lo. You might contact Steven Lo via mailing address: C/o Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park Ca 94010.